Page 2 - Cancer Drug

Govt slashes price of 390 non-scheduled cancer medicines by up to 87%

This move is expected to benefit 22 lakh cancer patients in the country and would result in annual savings of around Rs 800 crore to the patients

China agrees to lift tariffs on import of cancer drugs from India

However, it is not yet clear whether China has agreed to grant licences to Indian companies to sell cancer drug in the huge market

Intas launches chemotherapy drug at affordable price

It is estimated that every year over 700,000 patients die due to various types of cancer in India

Cancer drug: Supreme Court allows Cipla to withdraw appeal against Roche

The single judge had also refused to revoke the patent of the Swiss company as sought by Cipla

Special Court concerned over illegal access to anti-cancer drugs in Delhi

Drugs worth over Rs 50 lakh were seized from a pharma dealer in Karol Bagh on May 4

Cancer drug prices slashed up to 86% in a year: NPPA

The prices have been reduced in the range of 42% to 10%

Facing cancer drug shortage, US relies on banned Chinese plant

According to the Food and Drugs Administration, drugs sold in the US are held to the same standards regardless of manufacturing location